Roche Aktie

286,65 EUR +0,15 EUR +0,05 %

10:38:48

FSE

269,20 CHF +2,00 CHF +0,75 %

11:46:23

SWX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.227,26 Mrd. EUR

KGV24,60Div. Rendite3,80%

WKN855167

ISINCH0012032048

SymbolRHHVF

Roche Aktien News

Sortieren:Datum Meistgelesen

07.08.24BenzingaRoche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions

07.08.24Financial TimesRoche considers options for $1.9bn cancer data start-up

30.07.24GlobeNewswireEuropean Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO)

30.07.24Roche Holding AGEuropean Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO)

29.07.24FOX BusinessRoche ‘fast-tracking’ weight-loss drug that rivals Wegovy

29.07.24GlobeNewswireRoche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care

29.07.24Roche Holding AGRoche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care

29.07.24Financial TimesRoche to fast-track weight loss pill to compete with rivals

25.07.24ZacksRoche (RHHBY) Sales, Earnings Grow in 1H24, '24 EPS View Raised

25.07.24Roche Holding AG[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter - full-year earnings outlook raised

25.07.24GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised

23.07.24MotleyFoolLook Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?

22.07.24ZacksThe Zacks Analyst Blog Highlights Broadcom, Roche, Micron Technology and Moving iMage Technologies

22.07.24MotleyFoolBetter Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche

19.07.24ZacksTop Analyst Reports for Broadcom, Roche & Micron Technology

18.07.24GlobeNewswireNew data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions

18.07.24Roche Holding AGNew data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions

17.07.24MotleyFoolWhy Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped

17.07.24GlobeNewswireRoche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study

17.07.24Roche Holding AGRoche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study

17.07.24BenzingaPfizer And Roche Advance On Their Weight Loss Drug Journeys

17.07.24MarketWatchRoche obesity-pill trial results weigh on shares of Eli Lilly, Novo Nordisk

17.07.24ZacksRoche (RHHBY) Reports Positive Phase I Data on Obesity Drug

17.07.24MarketWatchRoche shares jump on drugmaker’s early-stage data on weight-loss drug

17.07.24BenzingaRoche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study

17.07.24GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity

17.07.24Roche Holding AG[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity

12.07.24ZacksRoche Holding's (RHHBY) Accu-Chek SmartGuide Receives CE Mark

10.07.24PR NewswireRemix Therapeutics™ Attains Near-Term Milestone from Roche Collaboration

09.07.24GlobeNewswireRoche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes

09.07.24Roche Holding AGRoche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes

08.07.24GlobeNewswireRoche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)

08.07.24Roche Holding AGRoche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)

08.07.24ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche

05.07.24ZacksRoche (RHHBY) Receives FDA Nod for Vabysmo Prefilled Syringe

05.07.24GlobeNewswireFDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

05.07.24Roche Holding AGFDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

04.07.24MarketWatchRoche to halt lung-cancer drug trial after disappointing data

04.07.24GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase II/III SKYSCRAPER-06 study in metastatic non-squamous non-small cell lung cancer

04.07.24Roche Holding AG[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase II/III SKYSCRAPER-06 study in metastatic non-squamous non-small cell lung cancer

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.